Drug Benefit News

Written By
Written For
AIS Guarantee
Shipping Information
Related Publications

Place an order or get more information at 800-521-4323

Order Now (Secure Site)
	Full Year
	Introductory
	View Cart

Full Year Subscription (24 issues): $537
Introductory Subscription (4 issues): $86
Format: 8 pages, print and e-mail
Frequency: Biweekly
ISSN: 1530-3438
Pub Code: NDBN

Drug Benefit News is a biweekly newsletter with:

Insight into events that have a big impact on pharmacy benefit costs, such as drug purchasing arrangements, lawsuits, Medicare Part D and more.
Strategic guidance from industry experts.
Exclusive data on high-cost drug categories.

Drug Benefit News focuses on issues and events that have a big impact on the pharmacy benefit and drug costs, including:

Ways that health reform will change the rules that health plans, PBMs and pharma companies must play by,
New plan designs to promote formulary compliance and the use of lower-cost therapeutic alternatives, including OTC products,
New strategies to manage biosimilars that will soon hit the U.S. market
Expected changes to the AWP pharmacy,
The move to reduce or eliminate copays on “high value” drugs,
Details of transparent PBM arrangements,
Use of evidence-based medicine to control drug costs.

Rely on Drug Benefit News for timely news and data on the business of pharmaceuticals ... and get practical cost management strategies from experts throughout the industry. Subscribe today!

Drug Benefit News is written by an editorial team with extensive experience in pharma/health care business publishing. Editor Renée Frojo (rfrojo@aispub.com) joined AIS in 2009 and has several years of experience covering pharmacy benefits and regulatory issues. Managing Editor Angela Maas has an extensive background in editing, reporting and writing for both trade and consumer publications. Angela also is the managing editor of AIS’s Web and e-mail news content, and the monthly newsletter Specialty Pharmacy News. Executive Editor Jill Brown is a veteran health care reporter who brings an intelligent perspective on the forces reshaping the health care industry. And AIS’s director of databases and directories, Susan Namovicz-Peat, contributes exclusive data from AIS’s Quarterly Survey of PBMs.

When you subscribe to Drug Benefit News, your satisfaction is fully guaranteed. If you are not completely satisfied with the newsletter within the first 30 days, just cancel and receive a prompt 100% refund. After your first 30 days, you may cancel at any time in the year ahead and receive a full prompt refund for all unmailed issues.

Your e-mail edition of the newsletter is sent on the day of publication. E-mail recipients should whitelist aisalert@aispub.com to ensure delivery.

Print newsletters are mailed 1st class through the US Postal Service. You should receive your first issue within 5-7 business days of your order.